Verve Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERV and other ETFs, options, and stocks.

About VERV

Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines.

CEO

Sekar Kathiresan

CEOSekar Kathiresan

Employees

113

Employees113

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2018

Founded2018

Employees

113

Employees113

VERV Key Statistics

Market cap

2.10B

Market cap2.10B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.65M

Average volume1.65M

High today

$36.38

High today$36.38

Low today

$34.13

Low today$34.13

Open price

$35.00

Open price$35.00

Volume

1.68M

Volume1.68M

52 Week high

$56.18

52 Week high$56.18

52 Week low

$10.70

52 Week low$10.70

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

VERV Earnings

-$2.13

-$1.42

-$0.71

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 10, Pre-Market

ActualExpected Nov 10, Pre-Market